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Abstract
The hybrid ventilation/perfusion (V/P) examination SPECT/CT improves the diagnostic accuracy of lung scintigraphy for pulmo-
nary embolism (PE). It reduces the false-positive results and increases the specificity of examinations. The co-registered V/P 
and CT scans provide more precise functional information, as well as additional data about pulmonary parenchyma, pleural and 
mediastinal structures. The CT acquisition is typically low-dose and can be implemented with little additional acquisition time and 
radiation exposure. It is convenient as a primary examination for patients with contrast-related contraindications, young patients 
and premenopausal women, because of the low whole body and breast exposure. It can be also used for the follow-up of the 
patients’ recovery, for functional quantification, radiotherapy planning and for the prediction of radiation-associated complications. 
Two clinical cases from our practice present the impact of SPECT/CT application in the primary diagnosis and in the follow-up 
of patients with pulmonary embolism.
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Introduction
The application of the new hybrid method SPECT/CT 
currently increases, by adopting more and more topics. The 
pulmonary ventilation (V) and perfusion (P) examinations were 
introduced almost 50 years ago. Recently they joined the 
SPECT/CT examinations. 
One of the frequent indications of V/P scanning is the diag-
nostics of pulmonary embolism (PE). It is clinically challenging 
and needs an imaging confirmation. V/P scanning was the 
first-line imaging test study until the advent of helical CT and CT 
pulmonary angiography (CTPA). The traditional problem with V/P 
scanning is the high incidence of indeterminate results. CTPA 
became the method of choice, visualizing directly the thrombi in 
the pulmonary tree (Figure 1). It is available in emergency situa-
tions, and convenient for differentiation of PE, myocardial infarc-
Figure 1. Contrast enhanced CT: CTPA. Visualization of the thrombi in 
the pulmonary tree
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tion, and aortic dissection. It also provides additional information 
about lung parenchyma and eventual pleural, pericardial and 
mediastinal pathology. The limitations of the method concern up 
to 23–31% of patients that may need imaging test [1, 2]. They are 
related to radiation exposure (high breast exposure unacceptable 
in premenopausal women: 20–50 mGy v/s 1.3 for V/P scan [3]), 
or to contrast contraindications (renal failure, severe contrast al-
lergy, diabetics on metformin). V/P SPECT /CT can replace CTPA 
in these patients. It is related to lower exposure (effective dose 
3.5 v/s 5–11 mSv). Its functional character facilitates the evalua-
tion of the defects’ resolution, and the detection of eventual new 
defects, which promote it as a test of choice for the follow-up. 
V/P examination has been recently re-evaluated especially 
with regard to its specificity (Sp) and inconclusive rate [4, 5]. 
Several improvements in registration and interpretation have 
been introduced:
Figure 2. Pulmonary segments
1. Change in the interpretation criteria — revised criteria 
(PIOPED II) with increase of Positive Predictive Value 
to 80% for PE of 0.5 segmental equivalent mismatched 
defect for patients without cardiopulmonary disease and 
2 segment equivalent mismatched defects for those with 
history of cardiopulmonary disease [5] (lung segments on 
Figure 2). 
2. Use of 99mTc labeled Technegaz as V-imaging agent permit-
ting a multiple view registration and “frozen images” after one 
inhalation, without central deposition. 
3. SPECT — registration, which provides the opportunity to 
visualize all lung segments, even medio-basal without su-
perimposition, and to detect 53% more defects [6, 7]. The 
detection rate of defects on the subsegmental level actually 
increases by 83% and at the segmental level — by 18% [4] 
(Figure 3).
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4. Hybrid examination with low-dose CT component (LDCT). 
5. The investigators have recently determined better sensitivity 
(S), specificity (Sp) and positive (PPV) and negative predictive 
values (NPV) and lower rate of inconclusive results for V/P 
SPECT and V/P SPECT/CT (Table 1).
Figure 3. Subsegmental defects on SPECT images in 3 planes (axial, coronal and sagittal) and 3-D rotating
Table 1. Comparison of CTPA and V/P scan (S, Sp PPV, NPV)
Time period CTPA V/P  
1990 S 95% S 84.9% Planar registration 
Inconclusive rate 0% Sp 80.1% PIOPED criteria [8]
Inconclusive rate 0%
S 80.4%
Introducing PISAPED criteria 
(perfusion only scintigraphy) [9–11]
Sp 96.6%
Inconclusive rate 0%
2004 S 86% S 97% Introducing SPECT [4]
  Sp 98% Sp 91%  
2008 S 68% S 97% Introducing SPECT/CT to V/P [12]
Sp 100% Sp 100%
PPV 100% PPV 100%
NPV 83% NPV 98% 
S 93% Introducing SPECT/CT to P [12]
Sp 51% 
PPV 57%
    NPV 91%  
2009 S 83% Agreement with CTPA 95% 
Sp 98% [13]
PPV 95%
    NPV 94%  
The recent data prove comparable sensitivity and specificity 
of CTPA and V/P SPECT/CT. The positive effect is due to the 
tomographic registration, as well as to the fusion with LDCT. 
LDCT attributes some perfusion defects to cardiomegaly, 
prominent hilum, effusions, atelectasis, bullae, or fissures in 
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one-moment tomographic registration (Figure 4, 5). Alternative 
diagnoses, such as granulomatous diseases, tumors, or metas-
tases (Figure 6), pneumonic consolidations lymphadenopathy, 
are frequent. That is why the CT component should be meticu-
lously included in the reporting. The fusion of SPECT and CT 
images can be problematic, with breathing artifacts (Figure 7). 
The mid-inspiration CT registration is recommended, or an au-
tomated breath-hold perfusion SPECT/CT registration [14]. 
The CT-component provides some evidences confirming 
PE: distal to the embolus focus of oligemia leading to vessel 
collapse (vascular rarefaction), infarction related consolidation 
of lung parenchyma (Hampton hump), or dilatation of pulmo-
nary trunk related to the pulmonary hypertension (Figure 8A, B, 
Figure 12A). 
The reporting should include the pretest probability of PE 
[European guidelines, 15]. The patients with cardio-pulmonary 
co-morbidity could be problematic for interpretation [16]. All 
patients with chronic obstructive pulmonary disease (COPD) 
have low CT lung attenuation areas (emphysema, or air trap-
ping, bulla or bronchial enlargement). All patients with interstitial 
lung disease have high CT attenuation areas representative of 
interstitial thickening. In COPD the areas with better preserved 
perfusion correspond to the areas with preserved parenchyma. 
These patients could have: matched or reverse mismatched 
defects (alveolar destruction, inflation and hypoxic vasocon-
striction, plugs, inflammation [17], or segmental mismatch 
(vascular remodeling or obliteration, or superimposed PE). 
This variety of defects makes the evaluation much more dif-
ficult (Figure 9). In congestive heart failure (CHF), an inverse 
deposition of the perfusion radiopharmaceutical, redistributed 
towards upper lung region, is present. The perfusion is more 
affected than the ventilation, but without segmental character, 
which permits the detection of eventual superimposed PE [18] 
(Figure 10).
Cases 1 and 2 demonstrate the diagnostic value and the impact 
of the appropriate use of SPECT/CT in lung examinations.
Case 1 (Figure 11A-C)
Thirty-year-old woman, after 2 hours of travel-flight, with 
acute pleuritic pain in the left thoracic wall, shortness of breath. 
Planar examination identified no definite defect. On SPECT/CT 
images — small zone of hypoperfusion and consolidation in 
the costo-diaphragmatic angle, pointing to the diagnosis of 
pulmonary embolism and pulmonary infarction. The patient 
was examined and found positive for Factor V Leiden gene 
abnormality, predisposing an increased risk of pulmonary 
venous thrombosis.
Figure 4. Fused images: A. plate-like atelectasis; B. bullae; C. cardiomegaly; 
D. bronchiectases
 A B
 C D
Figure 5. Fused images: A. small pleural effusion, related to PE; B. large effusion, without PE
 A B
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Case 2 (Figure 12A-C)
Twenty-eight-year-old woman, on contraceptives, with massive 
PE in the right lung, detected by CTPA. The follow-up was done by 
SPECT/CT, which after 2 months demonstrated partial resolution of 
perfusion abnormalities and of the pulmonary infarction in comparison 
with basal examination (Figure 12B by courtesy of D. Zlatareva from the 
Radiology Department of the University Hospital — “Alexandrovska”).
Discussion
Different opinions exist about the perfusion only SPECT/CT. Some 
authors declared that it cannot replace the ventilation scan [19]. 
Figure 6. Unexpected pathology: A. tumors; B. metastases
 A B
Figure 8. CT signs for PE: A. pulmonary trunk dilatation due to pulmonary hypertension; B. Westermark sign (vascular rarefaction); C. hemorrhages with 
fast resolution
 A B C
Figure 7. Breathing artifact
Figure 9. COPD — preserved perfusion in areas with preserved 
parenchyma
Figure 10. CHF — inverse distribution and superimposed PE
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The reported S is good — 93%, but the Sp is low — 51% with 18% 
inconclusive rate [12]. Difficulties can be expected in the interpreta-
tion in patients with COPD, because of the low-attenuation areas, 
which can mimic vascular rarefaction. Nevertheless, the perfusion 
only scintigraphy is also in use with recently reported S 82%, and 
specificity — 96% [10, 11]. The perfusion scan is attributed to 
4 categories: normal, nearly normal (with defects explained by 
CT-visualized structures), abnormal (with multiple wedge-shaped 
defects), abnormal (not suggestive PE). Unlike PIOPED (with 
probabilistic classification), in PISA-PED the results of perfusion 
lung scintigraphy alone categorize patients as positive, or nega-
tive. The criteria for PE are wedge shaped defects with segmental 
or sub-segmental distribution and usually wedge-shaped areas of 
overperfusion.
SPECT/CT can be very useful in functional quantification 
because of its regional accuracy, without superimposition of seg-
ments [20]. Semiquantitative evaluation of perfusion was proposed 
by dividing the lung into 18 segments, with 1-point for subsegmental 
loss, or segmental reduction, and 2 points for segmental loss [21]. 
A more precise, absolute quantification model, exists, taking into 
consideration the net activity applied, the attenuation and scatter 
correction [22].
Another possible application of SPECT/CT is the prediction 
of radiation-associated pulmonary damage. The acute damage 
— radiation pulmonitis can be found in 10% of patients (in relation 
Figure 11. Case 1. SPECT/CT for the diagnosis of PE with pulmonary 
infarction: A. planar examination; B. SPECT/CT; C. CTPA
 A
B
Figure 12. Case 2. SPECT/CT for the follow-up of young women with 
PE: A. basal SPECT/CT; B. CTPA; C. SPECT/CT follow-up
 A
B
C
C
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to the exposure, its fractionation, and lung volume with accumu-
lated dose > 20 Gy). Pulmonary fibrosis, as a sign of late toxicity 
appears 3–4 months later, up to 18 months after radiotherapy. 
The perfusion, measured at the 18th month is indicative for the 
long-term pulmonary function. The V/P scan is important to predict 
the effect of radiation on the pulmonary function in preexisting 
perfusion deficiency [23, 24]. A semi-quantitative SPECT/CT evalu-
ation was proposed [21] with lung perfusion score > 5 predictive 
for radiation related pulmonary complications. Another possible 
application is the defining the highly perfused lung regions for 
radiotherapy planning aimed at sparing them [25].
Conclusion
There are considerable benefits of SPECT/CT application in 
lung diseases evaluation (even when LDCT is fused only with 
perfusion scan): improved sensitivity, specificity, morphological 
details, detection of other pathology. No absolute contraindica-
tions exist; the examination is well tolerated by patients. Since a lot 
of patients who undergo CTPA do not have PE, lung SPECT/CT 
as an alternate to CTPA imaging modality with lower exposure and 
without side-effects should be promoted. 
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